STE vs TRDA · P/E 25, rev $5.46B vs P/E 12, rev $210.8M
STERIS plc (STE) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
STE currently screens at market cap $19.43B and trailing P/E 25.1. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the STE and TRDA stock pages for the full models.
Not investment advice.